Skip to content

Prevention & Promotion in the Treatment of Obesity

Prevention & Promotion in the Treatment of Obesity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02990494
Acronym
PROSPER
Enrollment
96
Registered
2016-12-13
Start date
2016-12-31
Completion date
2018-06-30
Last updated
2018-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

Making healthy food choices requires sacrificing immediate pleasures of consuming high calorie foods in order to achieve long-term health goals. Two strategies to encourage such future thinking are 1) focusing on the long-term consequences of consuming unhealthy foods, and 2) focusing on the long-term benefits of avoiding these unhealthy foods. Two novel behavioral weight loss (BWL) interventions will be developed based on these strategies (PREVENT and PROMOTE) and compared to standard Internet-delivered BWL to test their feasibility and efficacy in changing food choice decision-making, reducing food cravings, and ultimate weight loss.

Detailed description

Obesity is one of the most important public health issues today, contributing to many of the primary causes of morbidity and mortality in the United States. Still, treatment remains difficult and many people continually struggle to lose weight. Thus there is critical need for improvements in methods for treating obesity. One potential reason weight control is so difficult is the need to sacrifice immediate pleasures for long-term goals. This requires placing significant value on future outcomes, such as health. One strategy for doing so is to focus on the potential benefits of avoiding unhealthy choices. Health messaging studies suggest that messages focused on promoting long-term benefits of healthier choices may be effective in encouraging initiation of, or positive attitudes toward, healthy behaviors, however, longer-term effects of these messages have not been studied in the context of obesity. By contrast, behavioral economic work on Prospect Theory suggests focusing on preventing future negative consequences may be superior, and the threat of weight gain is a more powerful motivator than the benefit of weight loss. Although prevention strategies have been successfully employed in smoking cessation and anti-smoking campaigns, they are not typically used in obesity treatment. In promising preliminary neuroimaging work, the investigators identified increases in brain regions involved in inhibitory control and decreases in cravings when using this PREVENT strategy. The goal of this R03 is to test whether an intervention built upon the goal to PREVENT long-term consequences of weight gain versus an intervention built upon the goal to PROMOTE long-term benefits of weight loss is beneficial in altering valuation of health and taste in food choice decision-making, encouraging adherence, reducing food cravings and consumption, and ultimate weight loss, as compared to a standard behavioral weight loss program (BWL). A total of 90 overweight/obese men and women will be randomly assigned to either PREVENT, PROMOTE, or standard BWL. Each intervention will have one in-person training session wherein participants will learn key strategies of their assigned program, and the remaining 12 weekly lessons will be delivered via internet. Baseline and 3-month (post-treatment) assessments will include the food choice decision-making task featured in the parent K01 to measure valuation of health and taste, weight measurement, and measurement of food cravings and consumption. To address feasibility, adherence and engagement measures (i.e., lessons viewed, self-monitoring) will be collected during the internet program, and memory for lesson content will be assessed post-treatment. Individual difference measures will also be collected to provide preliminary data on factors that may influence success in each arm. This project tests innovative approaches in the clinical treatment of obesity and will provide new insights into the potential role of prevention versus promotion strategies for weight loss.

Interventions

BEHAVIORALSTANDARD

Standard Internet-delivered behavioral weight loss

BEHAVIORALPREVENT

enhanced standard Internet-delivered behavioral weight loss program

BEHAVIORALPROMOTE

enhanced standard Internet-delivered behavioral weight loss program

Sponsors

The Miriam Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
25 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* ages 25-60 * currently overweight or obese (BMI 25-45 kg/m2)

Exclusion criteria

* lack of access to a computer and the Internet (needed once per week), * weight loss medications * neurological or psychiatric conditions including but not limited to schizophrenia, and bipolar disorder * inability to attend assessments * lack of interest in participating in a behavioral weight loss trial * serious current physical disease for which physician supervision of diet and exercise prescription is needed * physical problems that limit the ability to exercise * participation in a weight loss program within the last 2 months * intention to become pregnant in the next 3 months

Design outcomes

Primary

MeasureTime frame
Change in food choice decision-making taskbaseline baseline and within 30 days of intervention conclusion

Secondary

MeasureTime frameDescription
change in scale-measured body weightfrom baseline to within 30 days of intervention conclusion
adherence and acceptability questionnaireduring 12-week intervention and within 30 days of intervention conclusionassessing adherence (number of lessons viewed and self-monitoring data entered by participants) throughout the intervention and acceptability of the intervention following treatment
change in cravings and consumption questionnairefrom baseline to within 30 days of intervention conclusion

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026